EAACI Congress 2025
BackFT11 - Biologics and airway disease in pediatric care
Saturday 14 Jun, 15:00 PM -
16:30 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
15:00
000600
Dupilumab Reduces Exacerbations and Improves Asthma Control in Children With Moderate-to-Severe Type 2 Asthma, Regardless of Asthma Duration
15:07
000613
Dupilumab Reduces Seasonal Exacerbation Rates in Children With Type 2 Asthma With or Without Evidence of Allergy
15:14
001674
Study on the target level and influencing factors of dupilumab treatment in children with moderate to severe atopic dermatitis
15:21
001350
The effect of the community of residence on Wheeze/ asthma symptoms mediated through environmental risk factors and respiratory infection in children in southern Nigeria
15:28
000822
The Hints to Differentiate CAPs From Acute/Recurrent Acute Urticaria: A Multicenter Study
15:35
000186
Is Chronic Rhinosinusitis Still an Underestimated Disease?
15:42
001642
Evaluation of Asthma Course in Patients Hospitalized in Pediatric Intensive Care Unit Due to Severe Asthma Exacerbation
15:49
000582
How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis
15:56
000376
Untargeted metabolomics reveals the metabolic profiles of children with allergic asthma in eastern and western China
16:03
000234
Carboxylic Acid Metabolism and Key Biomarkers in Airway Allergic Diseases
